The Latest Kyleena Effectiveness Duration Statistics Explained
The Kyleena IUD is 99% effective at preventing pregnancy.
The statistic that the Kyleena IUD is 99% effective at preventing pregnancy means that out of every 100 women who use the Kyleena IUD as their method of birth control for a year, only one woman is likely to become pregnant. This high level of effectiveness makes the Kyleena IUD one of the most reliable forms of contraception available. It is a long-acting reversible contraceptive that is inserted into the uterus and works by releasing hormones to prevent pregnancy. However, it is important to note that no contraceptive method is 100% effective, and there is still a small chance of pregnancy even with the use of the Kyleena IUD.
Kyleena is effective for up to 5 years.
The statistic “Kyleena is effective for up to 5 years” indicates that the contraceptive device known as Kyleena is designed to provide contraceptive protection for a period of up to 5 years after insertion. This means that once Kyleena is inserted into the uterus, it can effectively prevent pregnancy for at least 5 years before it needs to be replaced or removed. The statement highlights the long-term efficacy of Kyleena as a method of birth control, making it a convenient option for individuals looking for a reliable contraceptive solution over an extended period of time.
Kyleena only has a failure rate of around 0.2% in the first year of proper use.
The statistic “Kyleena only has a failure rate of around 0.2% in the first year of proper use” indicates the likelihood of pregnancy occurring while using the Kyleena intrauterine device (IUD) correctly. This low failure rate of 0.2% suggests that out of 1000 women using Kyleena correctly for one year, only an estimated 2 may experience unintended pregnancies. Proper use of Kyleena involves correct insertion by a healthcare provider, regular check-ups to ensure it remains in place, and following the recommended usage guidelines. This statistic underscores the high effectiveness of Kyleena as a contraceptive method, making it a reliable option for women seeking long-term birth control with minimal risk of pregnancy.
Personal failure rate of Kyleena usage increases to about 2.6% after five years.
The statistic indicates that the personal failure rate of Kyleena usage, a type of intrauterine device (IUD) used for contraception, gradually increases to approximately 2.6% after five years of continuous usage. This means that over a five-year period, around 2.6% of individuals relying on Kyleena as their method of birth control may experience unintended pregnancies. The increase in failure rate over time suggests that the effectiveness of the device may diminish as it approaches the end of its recommended lifespan, highlighting the importance of regular monitoring, replacement, and communication with healthcare providers to ensure optimal contraceptive efficacy.
Approximately 77% of women use Kyleena IUD up to the full 5 year duration.
The statistic that approximately 77% of women use Kyleena IUD up to the full 5-year duration suggests that a significant majority of women who choose this intrauterine contraceptive device adhere to the recommended timeframe for its use. This statistic indicates a high level of satisfaction and efficacy of the Kyleena IUD, as it demonstrates that the majority of women find it to be a convenient and effective long-term birth control option. Additionally, this statistic is valuable for healthcare providers and policymakers in understanding the acceptance and retention rates of this particular contraceptive method among women.
Kyleena is suitable for women of all ages including those who have not given birth, making it diverse in its applicability.
The statistic suggests that Kyleena, a type of intrauterine device (IUD), is a suitable contraceptive option for women of various age groups, including those who have never given birth. This highlights the versatility and broad applicability of Kyleena as a contraceptive method, accommodating women at different stages of their reproductive life. By being suitable for nulliparous women as well as those who have given birth, Kyleena offers a diverse range of options for individuals seeking effective birth control. This statistic emphasizes that Kyleena is a flexible and inclusive contraceptive choice, providing women of all ages with a reliable and convenient form of birth control regardless of their childbirth history.
About 22% of women discontinue Kyleena use before 1 year.
The statistic “About 22% of women discontinue Kyleena use before 1 year” indicates that a significant proportion of women stop using the Kyleena intrauterine device (IUD) within the first year of insertion. This could be due to various reasons such as side effects, dissatisfaction with the device, or experiencing difficulties in using it. Understanding the discontinuation rate is important for healthcare providers and researchers to evaluate the effectiveness and acceptability of Kyleena among users, as well as to identify potential areas for improvement in the device or in counseling patients regarding its usage.
The continuation rate of Kyleena stands at 84.1% for nulliparous women, and 85.4% for parous women after one year.
The continuation rate statistic indicates the percentage of women who continue to use Kyleena, a type of intrauterine device (IUD), one year after its initial insertion. Specifically, the statistic shows that 84.1% of nulliparous women (women who have never given birth) and 85.4% of parous women (women who have given birth) continue to use Kyleena after one year. A higher continuation rate suggests a higher level of satisfaction with the contraceptive method and may indicate that women find Kyleena to be effective, convenient, and well-tolerated. These statistics can be valuable for healthcare providers, policymakers, and individuals considering the use of Kyleena as a contraceptive option.
Approx 32.6% of women found reduced menstrual bleeding after 1 year of Kyleena use.
The statistic indicates that out of the group of women studied, approximately 32.6% experienced a decrease in menstrual bleeding after using Kyleena for one year. This suggests that a significant proportion of women using Kyleena may benefit from a reduction in menstrual bleeding, which could have positive implications for their quality of life and overall health. However, it’s important to note that individual experiences may vary and not all women may experience the same effect. Additional research and data may be needed to further understand the impact of Kyleena on menstrual bleeding and to evaluate its effectiveness in a broader population.
12% of users stopped using Kyleena within the first year due to adverse effects.
The statistic ‘12% of users stopped using Kyleena within the first year due to adverse effects’ indicates that among individuals who had Kyleena, an intrauterine device (IUD) used for contraception, 12% of them discontinued usage within the first year specifically because they experienced adverse effects. This statistic suggests that a relatively small proportion of users may face adverse effects significant enough to lead them to discontinue using Kyleena within the first year of insertion. Adverse effects may include side effects such as spotting, changes in menstrual bleeding patterns, cramping, or other discomfort. Understanding this statistic can help healthcare providers counsel patients on potential risks and benefits associated with using Kyleena and guide decision-making regarding contraceptive options.
96% of women were able to successfully conceive within a year of removing the Kyleena IUD.
The statistic indicates that 96% of women who had the Kyleena intrauterine device (IUD) removed were able to conceive successfully within a year. This suggests that the majority of women who previously had the Kyleena IUD did not experience long-term fertility issues after its removal. This statistic can provide reassurance to women considering removing their IUD and trying to conceive. However, it is important to note that individual fertility outcomes can vary, and additional factors such as age, health conditions, and lifestyle considerations may also play a role in conception success.
About 10% of women stopped using Kyleena due to the expulsion of the device.
The statistic indicates that approximately 10% of women discontinued the use of the Kyleena intrauterine device (IUD) specifically because the device expelled from their uterus. This implies that a notable proportion of women experienced this particular issue as a reason for discontinuation. Device expulsion is a known complication of IUD use, where the device is pushed out of the uterus partially or completely. This statistic suggests that expulsion is a significant concern for some women using Kyleena as their chosen form of birth control, highlighting the importance of careful monitoring and support for individuals using this contraceptive method.
Only 3 to 5 out of 1000 users could experience the device going through the wall of the uterus.
The statistic indicates a very low probability of 0.3% to 0.5% (3 to 5 out of 1000) of users experiencing the device penetrating the wall of the uterus. This statistic suggests that the risk of this rare complication is minimal, but not insignificant, emphasizing the importance of proper device insertion techniques and monitoring by healthcare providers. Despite the low likelihood, users should be informed about this potential risk when considering the use of the device and be attentive to any symptoms that may indicate complications.
3 out of a 100 women could experience IUD’s shifting and moving from the site of implantation.
The statistic “3 out of 100 women could experience IUD’s shifting and moving from the site of implantation” refers to the estimated proportion of women who may encounter the displacement of their intrauterine device (IUD) after insertion. This statistic suggests that around 3% of women who use an IUD could potentially experience the device shifting from its original placement within the uterus. This movement of the IUD could lead to potential complications or discomfort for some individuals. It is essential for healthcare providers to ensure proper insertion and placement of the IUD, as well as for women to be aware of the signs of displacement and seek medical attention if they suspect any issues with their device.
Less than 1% of users reported device dislocation within one year of Kyleena use.
This statistic indicates that a very small proportion of users experience device dislocation within one year of using Kyleena, a type of intrauterine device (IUD). Specifically, less than 1% of users reported such an issue, suggesting that the likelihood of device displacement is extremely low among individuals using this contraceptive method. This information provides reassurance to healthcare providers and potential users regarding the safety and efficacy of Kyleena in terms of device placement and retention. It also highlights the importance of proper insertion by trained professionals to minimize the risk of dislocation for those opting for this form of birth control.
Around 5% of users reported moderate to severe pain during Kyleena insertion.
The statistic “Around 5% of users reported moderate to severe pain during Kyleena insertion” indicates that a small proportion of individuals experience significant discomfort during the insertion of the Kyleena intrauterine device (IUD). This finding suggests that while the majority of users may only experience mild discomfort or pain during the insertion procedure, a notable minority may have a more challenging and uncomfortable experience. Understanding the prevalence of moderate to severe pain during Kyleena insertion is important for healthcare providers and patients to have realistic expectations and be prepared to manage pain during the procedure.
More than 3.7 million Kyleena units were sold worldwide until 2018.
The statistic “More than 3.7 million Kyleena units were sold worldwide until 2018” indicates the significant popularity and widespread use of the Kyleena intrauterine device (IUD) as a form of contraception up to the year 2018. The large number of units sold suggests that Kyleena has been a widely accepted and preferred option among individuals seeking long-term contraceptive solutions globally. This statistic also highlights the impact and reach of Kyleena as a contraceptive choice for women, emphasizing its effectiveness and adoption in various regions around the world.
References
0. – https://www.www.cdc.gov
1. – https://www.www.ncbi.nlm.nih.gov
2. – https://www.www.mdedge.com
3. – https://www.www.verywellhealth.com
4. – https://www.www.plannedparenthood.org
5. – https://www.www.birthcontrol.com
6. – https://www.pubmed.ncbi.nlm.nih.gov
7. – https://www.www.bayer.com
8. – https://www.www.kyleena-us.com
